Abivax's lead drug candidate, obefazimod, is in phase 3 trials for ulcerative colitis, highlighting its potential in the biotech industry. The company faces financial challenges with a negative P/E r...
Wynn Nightlife introduces a cinematic short film,...
Phunware Inc. (NASDAQ:PHUN) reported an earnings ...
BitFuFu Inc. (NASDAQ: FUFU) Earnings Report Highlights – Full-Year 2025 Results BitFuFu Inc. (NASDAQ: FUFU) reported full-year 2025 revenue of $475.8 million, up 2.7% year-over-year, driven by
Bionano Genomics, Inc. (NASDAQ:BNGO) is set to release its quarterly earnings with Wall Street expecting a loss of $2.47 per share and analysts predicting a smaller loss of $1.40 per share. The
FedEx Corporation (NYSE: FDX) shares climbed nearly 2% intra-day Friday after the logistics company raised its full-year profit guidance, supported by improved package yields and cost reductions from
Shares of Arm Holdings (NASDAQ: ARM) rose more than 3% intra-day Friday after HSBC upgraded the stock to Buy from Reduce and raised its price target to $205 from $90. The firm said Arm is undergoing
Shares of SolarEdge Technologies (NASDAQ: SEDG) surged more than 14% intra-day Friday after Jefferies upgraded the stock to Hold from Underperform and raised its price target to $49 from $30. The fir
BofA Securities downgraded Mosaic (NYSE: MOS) to Neutral from Buy and lowered its price target to $30 from $33, citing delays in expected margin expansion for phosphate fertilizers. Shares fell more t
